Sohn, Ji Youn
(Department of Internal Medicine, Chonbuk National University Medical School)
Kim, So Ri (Department of Internal Medicine, Chonbuk National University Medical School) Park, Seoung Ju (Department of Internal Medicine, Chonbuk National University Medical School) Lee, Heung Bum (Department of Internal Medicine, Chonbuk National University Medical School) Lee, Yong Chul (Department of Internal Medicine, Chonbuk National University Medical School) Rhee, Yang Keun (Department of Internal Medicine, Chonbuk National University Medical School) |
1 | van Noord JA, Aumann JL, Janssens E, Verhaert J, Smeets JJ, Mueller A, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006;129: 509-17 DOI ScienceOn |
2 | Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease 2006 [Internet]. [place unknown]: Global Initiative for Chronic Obstructive Lung Disease; c2009. Available from: http://www.goldcopd.org |
3 | Cazzola M, Ando F, Santus P, Ruggeri P, Di Marco F, Sanduzzi A, et al. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe- to-very severe COPD. Pulm Pharmacol Ther 2007; 20:556-61 DOI ScienceOn |
4 | Di Marco F, Verga M, Santus P, Morelli N, Cazzola M, Centanni S. Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study. Respir Med 2006;100:1925-32 DOI ScienceOn |
5 | Postma DS, Boezen HM. Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004;126:96S-104S; discussion 59S-61S DOI PUBMED ScienceOn |
6 | Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/ fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008;177:19-26 DOI PUBMED ScienceOn |
7 | Woolcock AJ, Peat JK, Salome CM, Yan K, Anderson SD, Schoeffel RE, et al. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax 1987;42:361-8 DOI ScienceOn |
8 | Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59 Suppl 1:1-232 PUBMED |
9 | Tashkin DP, Altose MD, Bleecker ER, Connett JE, Kanner RE, Lee WW, et al. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 1992; 145:301-10 DOI PUBMED |
10 | Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9 DOI ScienceOn |
11 | Rijcken B, Schouten JP, Weiss ST, Speizer FE, van der Lende R. The relationship between airway responsiveness to histamine and pulmonary function level in a random population sample. Am Rev Respir Dis 1988; 137:826-32 DOI PUBMED ScienceOn |
12 | Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418-24 DOI ScienceOn |
13 | Grootendorst DC, Rabe KF. Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:77-87 DOI ScienceOn |
14 | Ernst P, Ghezzo H, Becklake MR. Risk factors for bronchial hyperresponsiveness in late childhood and early adolescence. Eur Respir J 2002;20:635-9 DOI ScienceOn |
15 | Rhee YK, In BH, Lee YD, Lee YC, Lee HB. Prevalence of combined bronchial asthma with COPD in patients with moderate to severe air flow limitation. Tuberc Respir Dis 2003;54:386-94 |
16 | Niewoehner DE. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"? COPD 2009;6: 1-3 DOI ScienceOn |
17 | Seemungal T, Stockley R, Calverley P, Hagan G, Wedzicha JA. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology. COPD 2007;4:177-83 DOI ScienceOn |
18 | Trigg CJ, Manolitsas ND, Wang J, Calderon MA, Mc- Aulay A, Jordan SE, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150:17-22 DOI PUBMED ScienceOn |
19 | Onoue S, Misaka S, Kawabata Y, Yamada S. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy. Expert Opin Drug Deliv 2009;6:793-811 DOI ScienceOn |
20 | Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007;146:545-55 DOI ScienceOn |
21 | Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008;31:742-50 DOI ScienceOn |
22 | Xu X, Rijcken B, Schouten JP, Weiss ST. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997;350: 1431-4 DOI ScienceOn |
23 | Burney PG, Britton JR, Chinn S, Tattersfield AE, Papacosta AO, Kelson MC, et al. Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax 1987;42:38-44 DOI ScienceOn |
24 | Britton J, Pavord I, Richards K, Knox A, Wisniewski A, Wahedna I, et al. Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibre. Eur Respir J 1994;7:881-7 PUBMED ScienceOn |
25 | Keating GM, McCormack PL. Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease. Drugs 2007;67:2383- 405 DOI ScienceOn |
26 | Kraft M. Asthma and chronic obstructive pulmonary disease exhibit common origins in any country! Am J Respir Crit Care Med 2006;174:238-40 DOI PUBMED ScienceOn |